ALK and lung cancer: 44 Masuda Masuda N. N. Ohe Ohe Y. Y. Gemma Gemma A. A. Kusumoto Kusumoto M. M. Yamada Yamada I. I. Ishii Ishii T. T. Yamamoto Yamamoto N. N. Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non–small-cell lung cancer in Japan Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non–small-cell lung cancer in Japan Cancer Sci. Cancer Sci. 110 110 2019 2019 1401 1401 1407 1407 10.1111/cas.13977 10.1111/cas.13977 30776174 30776174